MENU
+Compare
SONN
Stock ticker: NASDAQ
AS OF
Sep 17 closing price
Price
$7.06
Change
+$0.58 (+8.95%)
Capitalization
44.24M

SONN Sonnet BioTherapeutics Holdings Inc Forecast, Technical & Fundamental Analysis

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company... Show more

SONN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SONN with price predictions
Sep 17, 2025

Momentum Indicator for SONN turns positive, indicating new upward trend

SONN saw its Momentum Indicator move above the 0 level on September 11, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned positive. In of the 87 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for SONN just turned positive on September 10, 2025. Looking at past instances where SONN's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .

SONN moved above its 50-day moving average on September 12, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SONN crossed bullishly above the 50-day moving average on September 17, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where SONN advanced for three days, in of 190 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 75 cases where SONN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SONN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SONN broke above its upper Bollinger Band on September 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SONN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (35.587) is normal, around the industry mean (19.637). P/E Ratio (0.288) is within average values for comparable stocks, (53.583). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.168). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (19.157) is also within normal values, averaging (331.570).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SONN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
SONN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a company, which engages in the development of biologic drugs with enhanced single or bispecific mechanisms

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
100 Overlook Center
Phone
+1 609 375-2227
Employees
12
Web
https://www.sonnetbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NVO58.201.00
+1.75%
Novo-Nordisk A/S
TE1.770.02
+1.14%
T1 Energy Inc.
HOPE10.840.09
+0.84%
Hope Bancorp
ESAB109.530.71
+0.65%
ESAB Corp
PRTS0.76-0.03
-3.66%
CarParts.com

SONN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SONN has been closely correlated with PTHS. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if SONN jumps, then PTHS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SONN
1D Price
Change %
SONN100%
+9.26%
PTHS - SONN
70%
Closely correlated
+2.09%
PRME - SONN
27%
Poorly correlated
-0.54%
DWTX - SONN
27%
Poorly correlated
+0.41%
JSPR - SONN
26%
Poorly correlated
-3.70%
PHAR - SONN
25%
Poorly correlated
+5.04%
More

Groups containing SONN

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SONN
1D Price
Change %
SONN100%
+9.26%
SONN
(2 stocks)
37%
Loosely correlated
+5.68%